BN Business News
Add your company to Business Communicator →

Business · 14/02/2002Updated: 10/17/2026 · 1 min read

FDA Approves Supplemental New Animal Drug Application for Florfenicol Injectable Solution

Summary

The US Food and Drug Administration (FDA) has amended animal drug regulations to reflect approval of a supplemental new animal drug application filed by Schering-Plough Animal Health Corp., which allows for a change in the pathogen genus on labeling of florfenicol injectable solution.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →